- Investing Ideas
- U.S. Pharmaceuticals & Biotech High Growth Stocks
U.S. Pharmaceuticals & Biotech High Growth Stocks
Results
5
High Growth Stocks
5 companies
Zevra Therapeutics
Market Cap: US$679.4m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.18
7D
-5.9%
1Y
25.6%
Kiniksa Pharmaceuticals International
Market Cap: US$6.1b
A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
KNSA
US$77.83
7D
1.7%
1Y
133.9%
Arcutis Biotherapeutics
Market Cap: US$3.3b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$25.83
7D
-2.3%
1Y
61.6%
BeOne Medicines
Market Cap: US$40.8b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$356.40
7D
8.1%
1Y
15.1%
Sotera Health
Market Cap: US$5.4b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$19.02
7D
0.6%
1Y
20.7%